# Plumas Bancorp: financial statements, quarterly

PLBC · Nasdaq · CIK 1168455 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/plbc.md) · [Financials](/companies/plbc/financials.md) · [Filings](/companies/plbc/filings.md) · [Insiders](/companies/plbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/plbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.7](/filings/0001437749-24-033515.md) | not reported | [0.7](/filings/0001437749-25-014933.md) | [0.7](/filings/0001437749-25-024964.md) | [0.8](/filings/0001437749-25-033185.md) | not reported | [0.7](/filings/0001437749-25-014933.md) | [0.8](/filings/0001437749-25-024964.md) | [0.8](/filings/0001437749-25-033185.md) | not reported | not reported | not reported |
| Interest expense | $m | [1.3](/filings/0001437749-23-030825.md) | [1.9 d](/filings/0001437749-24-008616.md) | [2.6](/filings/0001437749-24-014989.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.8](/filings/0001437749-24-033515.md) | [2.6 d](/filings/0001437749-26-008956.md) | [2.1](/filings/0001437749-25-014933.md) | [2.5](/filings/0001437749-25-024964.md) | [2.9](/filings/0001437749-25-033185.md) | [2.9 d](/filings/0001437749-26-008956.md) | [2.9](/filings/0001437749-26-015036.md) | [2.4](/filings/0001437749-26-025819.md) | [1.8](/filings/0001437749-25-033185.md) | [3.0 d](/filings/0001437749-26-008956.md) | [3.4](/filings/0001437749-26-015036.md) | [3.7](/filings/0001437749-26-025819.md) |
| Net income | $m | [8.0](/filings/0001437749-24-033515.md) | [7.5 d](/filings/0001437749-26-008956.md) | [6.3](/filings/0001437749-25-014933.md) | [6.8](/filings/0001437749-25-024964.md) | [7.8](/filings/0001437749-25-033185.md) | [7.7 d](/filings/0001437749-26-008956.md) | [7.2](/filings/0001437749-26-015036.md) | [6.3](/filings/0001437749-26-025819.md) | [5.1](/filings/0001437749-25-033185.md) | [11.0 d](/filings/0001437749-26-008956.md) | [9.8](/filings/0001437749-26-015036.md) | [10.0](/filings/0001437749-26-025819.md) |
| Diluted EPS | $ per share | [1.34](/filings/0001437749-24-033515.md) | not reported | [1.05](/filings/0001437749-25-014933.md) | [1.14](/filings/0001437749-25-024964.md) | [1.31](/filings/0001437749-25-033185.md) | not reported | [1.20](/filings/0001437749-26-015036.md) | [1.05](/filings/0001437749-26-025819.md) | [0.73](/filings/0001437749-25-033185.md) | not reported | [1.38](/filings/0001437749-26-015036.md) | [1.41](/filings/0001437749-26-025819.md) |
| Basic EPS | $ per share | [1.36](/filings/0001437749-24-033515.md) | not reported | [1.06](/filings/0001437749-25-014933.md) | [1.15](/filings/0001437749-25-024964.md) | [1.33](/filings/0001437749-25-033185.md) | not reported | [1.21](/filings/0001437749-26-015036.md) | [1.07](/filings/0001437749-26-025819.md) | [0.74](/filings/0001437749-25-033185.md) | not reported | [1.40](/filings/0001437749-26-015036.md) | [1.43](/filings/0001437749-26-025819.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [90.6](/filings/0001437749-23-030825.md) | [85.7](/filings/0001437749-25-008351.md) | [128](/filings/0001437749-24-014989.md) | [110](/filings/0001437749-24-025028.md) | [118](/filings/0001437749-24-033515.md) | [82.0](/filings/0001437749-26-008956.md) | [87.3](/filings/0001437749-25-014933.md) | [79.3](/filings/0001437749-25-024964.md) | [87.3](/filings/0001437749-25-033185.md) | [80.6](/filings/0001437749-26-025819.md) | [62.9](/filings/0001437749-26-015036.md) | [136](/filings/0001437749-26-025819.md) |
| Total assets | $m | [1,573](/filings/0001437749-23-030825.md) | [1,610](/filings/0001437749-25-008351.md) | [1,640](/filings/0001437749-24-014989.md) | [1,642](/filings/0001437749-24-025028.md) | [1,664](/filings/0001437749-24-033515.md) | [1,623](/filings/0001437749-26-008956.md) | [1,633](/filings/0001437749-25-014933.md) | [1,629](/filings/0001437749-25-024964.md) | [2,229](/filings/0001437749-25-033185.md) | [2,239](/filings/0001437749-26-025819.md) | [2,200](/filings/0001437749-26-015036.md) | [2,278](/filings/0001437749-26-025819.md) |
| Total liabilities | $m | [1,453](/filings/0001437749-23-030825.md) | [1,463](/filings/0001437749-25-008351.md) | [1,479](/filings/0001437749-24-014989.md) | [1,477](/filings/0001437749-24-025028.md) | [1,482](/filings/0001437749-24-033515.md) | [1,445](/filings/0001437749-26-008956.md) | [1,446](/filings/0001437749-25-014933.md) | [1,435](/filings/0001437749-25-024964.md) | [1,983](/filings/0001437749-25-033185.md) | [1,977](/filings/0001437749-26-025819.md) | [1,935](/filings/0001437749-26-015036.md) | [2,006](/filings/0001437749-26-025819.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [120](/filings/0001437749-24-033515.md) | [147](/filings/0001437749-26-008956.md) | [161](/filings/0001437749-25-024964.md) | [165](/filings/0001437749-25-033185.md) | [182](/filings/0001437749-25-033185.md) | [178](/filings/0001437749-26-025819.md) | [188](/filings/0001437749-26-025819.md) | [193](/filings/0001437749-26-025819.md) | [246](/filings/0001437749-25-033185.md) | [261](/filings/0001437749-26-025819.md) | [265](/filings/0001437749-26-025819.md) | [272](/filings/0001437749-26-025819.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.4 d](/filings/0001437749-24-033515.md) | [0.5 d](/filings/0001437749-26-008956.md) | [9.2](/filings/0001437749-25-014933.md) | [5.1 d](/filings/0001437749-25-024964.md) | [8.0 d](/filings/0001437749-25-033185.md) | [8.3 d](/filings/0001437749-26-008956.md) | [7.5](/filings/0001437749-26-015036.md) | [2.1 d](/filings/0001437749-26-025819.md) | [5.6 d](/filings/0001437749-25-033185.md) | [6.4 d](/filings/0001437749-26-008956.md) | [9.4](/filings/0001437749-26-015036.md) | [11.7 d](/filings/0001437749-26-025819.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001437749-24-033515.md) | [0.3 d](/filings/0001437749-26-008956.md) | [0.2](/filings/0001437749-25-014933.md) | [0.2 d](/filings/0001437749-25-024964.md) | [0.1 d](/filings/0001437749-25-033185.md) | [0.1 d](/filings/0001437749-26-008956.md) | [0.2](/filings/0001437749-26-015036.md) | [0.0 d](/filings/0001437749-26-025819.md) | [0.8 d](/filings/0001437749-25-033185.md) | [0.3 d](/filings/0001437749-26-008956.md) | [0.1](/filings/0001437749-26-015036.md) | [0.1 d](/filings/0001437749-26-025819.md) |
| Dividends paid | $m | [1.5 d](/filings/0001437749-24-033515.md) | [1.5 d](/filings/0001437749-26-008956.md) | [1.6](/filings/0001437749-25-014933.md) | [1.6 d](/filings/0001437749-25-024964.md) | [1.6 d](/filings/0001437749-25-033185.md) | [1.6 d](/filings/0001437749-26-008956.md) | [1.8](/filings/0001437749-26-015036.md) | [1.8 d](/filings/0001437749-26-025819.md) | [2.1 d](/filings/0001437749-25-033185.md) | [2.1 d](/filings/0001437749-26-008956.md) | [2.3](/filings/0001437749-26-015036.md) | [2.3 d](/filings/0001437749-26-025819.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001437749-26-015036.md) | [0.0 d](/filings/0001437749-26-025819.md) | not reported | not reported | [2.0](/filings/0001437749-26-015036.md) | [0.8 d](/filings/0001437749-26-025819.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,895](/filings/0001437749-23-030825.md) | [5,940](/filings/0001437749-24-014989.md) | [5,929](/filings/0001437749-24-025028.md) | [5,932](/filings/0001437749-24-033515.md) | [5,946](/filings/0001437749-25-014933.md) | [5,946](/filings/0001437749-25-024964.md) | [5,968](/filings/0001437749-25-033185.md) | [6,002](/filings/0001437749-26-015036.md) | [6,006](/filings/0001437749-26-025819.md) | [7,031](/filings/0001437749-25-033185.md) | [7,073](/filings/0001437749-26-015036.md) | [7,058](/filings/0001437749-26-025819.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,959,016 at 2026-08-01, from the cover of the [10-Q filed 2026-08-05](/filings/0001437749-26-025819.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.